Derivados de Quinazolina e Quinolina
As quinazolinas e quinolinas são compostos heterocíclicos contendo nitrogénio, com estruturas aromáticas que desempenham um papel fundamental na síntese de fármacos com atividade anticancerígena, antimicrobiana e anti-inflamatória. Os seus derivados apresentam modificações estruturais que otimizam a biodisponibilidade e a seletividade, permitindo o desenvolvimento de novos princípios ativos para diversas aplicações terapêuticas. Estes compostos são utilizados na fabricação de APIs para o tratamento do câncer, infeções, doenças neurodegenerativas e cardiovasculares. Além disso, os derivados de quinazolina e quinolina são essenciais na investigação de inibidores enzimáticos e no desenvolvimento de moléculas bioativas inovadoras.
Na CymitQuimica, oferecemos derivados de quinazolina e quinolina de alta pureza para aplicações em síntese química, desenvolvimento farmacêutico e biotecnologia.
Foram encontrados 65630 produtos de "Derivados de Quinazolina e Quinolina"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
rac Sulpiride
CAS:Produto Controlado<p>Applications An antipsychotic drug used in the treatment of Schozophrenia and depression.<br>References Kramer, P., et al.: J. Neurosci., 31, 126 (2011), Alelyunas, Y., et al.: Bioorg. Med. Chem. Lett., 20, 7312, (2010),<br></p>Fórmula:C15H23N3O4SCor e Forma:Off-WhitePeso molecular:341.43(R)-Pramipexole-d3 Dihydrochloride
CAS:Produto Controlado<p>Applications Labelled (R)-Pramipexole enantiomer. A dopamine-D2-receptor agonist. Antiparkinsonian.<br>References Mierau, J., et al.: J. Med. Chem., 30, 494 (1987), Schilling, J.C., et al.: Clin. Pharmacol. Ther., 51, 541 (1992), Kieburtz, K., et al.: J. Am. Med. Assoc., 278, 125 (1997)<br></p>Fórmula:C10H16D3Cl2N3SCor e Forma:NeatPeso molecular:287.27Lercanidipine 5-Desmethyl-5-Propyl Ester
CAS:<p>Applications Lercanidipine 5-Desmethyl-5-Propyl Ester is an impurity of the dihydropyridine calcium channel blocker Lercanidipine (L179000).<br></p>Fórmula:C38H45N3O6Cor e Forma:NeatPeso molecular:639.7804Nifedipine
CAS:Produto Controlado<p>Applications Used as an antihypertensive and antianginal. A dihydorpyridine calcium channel blocker.<br>References Ali, S.L., et al.: Anal. Profiles Drug Subs., 18, 221 (1989), Soons, P.A., et al.: J. Pharm. Biomed. Anal., 9, 475 (1991), Brown, M.J., et al.: Lancet, 356, 366 (2000),<br></p>Fórmula:C17H18N2O6Cor e Forma:Light YellowPeso molecular:346.333-Phenylquinoxaline-5-carboxylic acid
CAS:Pureza:95.0%Cor e Forma:SolidPeso molecular:250.257003784179710,11-Dihydro-11-[4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]dibenzo[b,f][1,4]thiazepin-11-ol
CAS:Produto Controlado<p>Applications Quetol is an impurity of Quetiapine(Q509900) a dibenzothiazepine antipsychotic commonly used as monotherapy for patients with major depressive disorder and schizophrenia.<br>References Cutler, A., et al.: J. Clin. Psych., 70, 526 (2009); Kapur, S., et al.: Arch. Gen. Psych., 57, 553 (2000); Peuskens, J. & Link, C.: Acta. Psych. Scand., 96, 265 (1997)<br></p>Fórmula:C21H27N3O3SCor e Forma:YellowPeso molecular:401.522Gabapentin Related Compound D
CAS:<p>Impurity Gabapentin EP Impurity D; Gabapentin USP Related Compound D<br>Applications Gabapentin Related Compound D (Gabapentin EP Impurity D; Gabapentin USP Related Compound D) is a Gabapentin analogue.<br></p>Fórmula:C18H29NO3Cor e Forma:White To Off-WhitePeso molecular:307.43Pibrentasvir
CAS:Produto Controlado<p>Applications Pibrentasvir (CAS# 1353900-92-1) is an antiviral used for hepatitis C virus NS3/4A protease inhibition.<br>References Ng, T. I.; et al.: Antimicrob. Agents Chemother., 62, 1 (2018).<br></p>Fórmula:C57H65F5N10O8Cor e Forma:Off-White To Light YellowPeso molecular:1113.181-(3,4-Dichlorophenyl)piperazine
CAS:Produto ControladoFórmula:C10H12Cl2N2Cor e Forma:NeatPeso molecular:231.123-Hydroxy-1-adamantyl-D-glycine
CAS:Produto Controlado<p>Applications 3-Hydroxy-1-adamantyl-D-glycine is a non-proteinogenic amino acid and a key intermediate required for the synthesis of Saxagliptin (S143500).<br>References Hanson, Ronald L., et al.: Advanced Synthesis & Catalysis, 349(8+9), 1369-1378 (2007)<br></p>Fórmula:C12H19NO3Cor e Forma:NeatPeso molecular:225.287-(4-Iodobutoxy)-3,4-dihydroquinolin-2-one
CAS:Produto Controlado<p>Impurity Aripiprazole Iodobutoxyquinoline Impurity<br>Applications An impurity in the synthesis of Aripiprazole (A771000). A degradation product in Aripiprazole tablets. Aripiprazole Iodobutoxyquinoline Impurity<br>References Shah, V., et al.: J. Pharm. Sci., et al.: 81, 309 (1992), Zuo, X., et al.: Chromatographia, 64, 387 (2006),<br></p>Fórmula:C13H16INO2Cor e Forma:Off-WhitePeso molecular:345.18[4-(5-pyridin-3-yl-1H-1,2,4-triazol-3-yl)phenyl]amine
CAS:Pureza:95.0%Peso molecular:237.266006469726562-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid
CAS:Pureza:95.0%Cor e Forma:SolidPeso molecular:298.27301025390625N-Nitroso Desmethyldiphenhydramine
CAS:Produto ControladoFórmula:C16H18N2O2Cor e Forma:NeatPeso molecular:270.3264-Pyrazol-1-ylmethyl-phenylamine
CAS:Fórmula:C10H11N3Pureza:98%Cor e Forma:SolidPeso molecular:173.219Minoxidil β-D-Glucuronide
CAS:Produto Controlado<p>Applications Minoxidil β-D-Glucuronide is a metabolite of Minoxidil (M345000), an antihypertensive and antialopecia agent. Minoxidil activates ATP-activated K+ channels.<br>References Thomas, R.C., et al.: J. Pharmaceut. Sci., 64, 1366 (1975),<br></p>Fórmula:C15H23N5O7Cor e Forma:White To BrownPeso molecular:385.377-Hydroxy Quetiapine
CAS:Produto Controlado<p>Stability Hygroscopic<br>Applications A metabolite of Quetiapine, a Benzothiazepine with mixed serotonin and dopamine receptor antagonistic properties used as an antipsychotic.<br>References Newton, D., et al.: Drug Metab. Dispos., 23, 154 (1995), Tanaka, E., et al.: J. Clin. Pharm. Ther., 24, 7 (1999)<br></p>Fórmula:C21H25N3O3SCor e Forma:WhitePeso molecular:399.515-Methyl-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazole-3-carboxylic acid
CAS:Peso molecular:210.233001708984382,3-Diphenylquinoxaline
CAS:Pureza:98.0%Cor e Forma:Solid, White - Pale reddish yellow powderPeso molecular:282.34600830078125Oxethazaine
CAS:Oxethazaine (Oxetacaine), a topical anesthetic, is used to prevent acid-induced esophageal pain.Fórmula:C28H41N3O3Pureza:99.875% - 99.94%Cor e Forma:Physical Description White Powder (Ntp 1992)Peso molecular:467.645-Benzo[1,3]dioxol-5-yl-1 H -pyrazole-3-carboxylic acid
CAS:Cor e Forma:SolidPeso molecular:232.195007324218752-(4-aminophenyl)-3-pyridinol dihydrochloride
CAS:Fórmula:C11H12Cl2N2OPureza:95.0%Cor e Forma:SolidPeso molecular:259.136,7-Dimethoxyquinazoline-4-one
CAS:<p>Applications Gefitinib intermediate.<br>References Kelly, L., et al.: Cancer Cell., 1, 421 (2002), Pandey, A., et al.: J. Med. Chem., 45, 3772 (2002), Ciardiello, F., et al.: Exp. Opin Emerg. Drugs, 8, 501 (2003), Caponigro, F., et al.: Curr. Opin Oncol., 16, 225 (2004),<br></p>Fórmula:C10H10N2O3Cor e Forma:NeatPeso molecular:206.203-(2-Amino-6-(1-((6-(2-hydroxypropan-2-yl)pyridin-2-yl)methyl)-1H-1,2,3-triazol-4-yl)pyrimidin-4-yl)-2-methylbenzonitrile
CAS:Pureza:98.0%Peso molecular:426.4840087890625Famotidine Sulfoxide
CAS:Produto Controlado<p>Applications An intermediate in the synthesis of the metabolite of the drug Famotidine (F102250(P)), which is a histamine H2-receptor antagonist and an antiulcerative.<br>References Takeda, M., et al.: Arzneim.-Forsch., 32, 734 (1982), Miwa, M., et al.: J. Clin. Pharmacol. Ther. Toxicol., 22, 214 (1984), Takabatke, T., et al.: Eur. J. Clin. Pharmacol., 28, 327 (1985),<br></p>Fórmula:C8H15N7O3S3Cor e Forma:NeatPeso molecular:353.44Raltegravir
CAS:Produto Controlado<p>Applications Raltegravir (MK-0518) is a potent integrase (IN) inhibitor for WT and S217Q PFV IN.<br>References Hare, S., et al.: Proc. Natl. Acad. Sci. U. S. A., 107, 20057 (2010); Hicks, C., et al.: Clin. Infect. Dis., 48, 931 (2009); Moss, D., et al.: Antimicrob. Agents Chemother., 56, 3020 (2012); Hare, S., et al.: Mol. Pharmacol., 80, 565 (2011)<br></p>Fórmula:C20H21FN6O5Cor e Forma:NeatPeso molecular:444.42Ticagrelor
CAS:Produto Controlado<p>Stability Hygroscopic<br>Applications Ticagrelor, the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS).<br>References Matetzky, S., et al.: Circulation, 109, 3171 (2004), Bassand, J., et al.: Eur. Heart J., 28, 1598 (2007), Jakubowski, J., et al.: Cardiovasc. Drug Rev., 25, 357 (2007),<br></p>Fórmula:C23H28F2N6O4SCor e Forma:WhitePeso molecular:522.57(E)-2-Chloro-3-imino-N,N-dimethylprop-1-en-1-amine Hydrochloride
CAS:Produto Controlado<p>Applications (E)-2-chloro-3-imino-N,N-dimethylprop-1-en-1-amine Hydrochloride is an impurity of Etoricoxib (E934100), a selective cyclo-oxygenase-2 (COX-2) inhibitor that is used to improve the signs and symptoms of osteoarthritis and rheumatoid arthritis.<br>References Hunt, R., et al.: Am. J. Gastroenterol., 98, 1725 (2003); Schumacher Jr., H., et al.: Bmj, 324, 1488 (2002)<br></p>Fórmula:C5H9ClN2·HClCor e Forma:Light YellowPeso molecular:169.05Irbesartan-d4
CAS:Produto Controlado<p>Applications Irbesartan-d4 is the labeled analogue of Irbesartan (I751000), an angiotensin II type 1 (AII1)-receptor antagonist.<br>References Gillis, J.C. and Markham, A.: Drugs, 54, 885 (1997); Chando, T.J., et al.: Drug. Metabol. Dispos., 26, 408 (1998); Massie, B., et al.: New Eng. J. Med., 359, 2456 (2008); Ren, X., et al.: Pharmacol., 83, 80 (2009)Aromatics, Heterocycles, Inhibitors, Isotope Labelled Compounds, Pharmaceuticals, Intermediates & Fine Chemicals<br></p>Fórmula:C25H24D4N6OCor e Forma:NeatPeso molecular:432.552-Oxazolidinone
CAS:Produto Controlado<p>Applications An oxazole derivative used as an antibiotic. It is also used in the preparation of compounds with antitumor activity. A metabolite of Furazolidone (F864100).<br>References Miyahara, M. et al.: CHem. Pharmac. Bull., 29, 2366 (1981); Hunder, G. et al.: Arch. Toxicol., 61, 161 (1987); Roloff, T. et al.: Med. Monat. Pharrm., 22, 370 (1999);<br></p>Fórmula:C3H5NO2Cor e Forma:NeatPeso molecular:87.08Lansoprazole N-Oxide
CAS:Produto Controlado<p>Impurity Lansoprazole EP Impurity A<br>Applications Lansoprazole N-Oxide (Lansoprazole EP Impurity A) is an impurity of Lansoprazole (L175000) formed during the bulk synthesis of the drug.<br>References Kubo, K., et al.: Chem. Pharm. Bull., 38, 2853 (1990), Barradell, L., et al.: Drugs, 44, 225 (1992), Aydogmus, Z., et al.: Acta Pharm. Sci., 48, 45 (2006),<br></p>Fórmula:C16H14F3N3O3SCor e Forma:NeatPeso molecular:385.36rac,trans-Milnacipran Hydrochloride
CAS:Produto Controlado<p>Applications rac,trans-Milnacipran Hydrochloride is an impurity of rac-Milnacipran Hydrochloride (M344600), an antidepressant and a selective norepinephrine and serotonin reuptake inhibitor.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Moret, C., et al.: Neuropharmacology, 24, 1211 (1985), Palmier, C., et al.: Eur. J. Clin. Pharmacol., 37, 235 (1989), Spencer, C.M., et al.: Drugs, 56, 405 (1998)<br></p>Fórmula:C15H23ClN2OCor e Forma:NeatPeso molecular:282.812-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-3-bromopropan-2-ol
CAS:Produto Controlado<p>Impurity Fluconazole EP Impurity H<br>Applications 2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-3-bromopropan-2-ol (Fluconazole EP Impurity H) is an impurity of the antifungal agent Fluconazole (F421000).<br>References Bourichi, H., et al.: STP Pharma Pratiques, 18, 285 (2008); Richard, K. et al.: Antimicrob. Ag. Chemother., 27, 832 (1985)<br></p>Fórmula:C11H10BrF2N3OCor e Forma:Off-WhitePeso molecular:318.12Desacetyl Triflusal
CAS:<p>Applications The active metabolite of Triflusal; inhibits cardiac hypertrophy in vitro and in vivo by blocking the NF-κB signaling pathway.<br>References Bayon, Y., et al.: Br. J. Pharmacol., 126, 1359 (1999), Cabrero, A., et al.: Diabetes, 50, 1883 (2001), Cabrero, A., et al.: J. Biol. Chem., 277, 10100 (2002), Culebras, A., et al.: Neurology, 62, 1073 (2004),<br></p>Fórmula:C8H5F3O3Cor e Forma:NeatPeso molecular:206.122-(5-amino-3-cyclopropyl-1H-pyrazol-1-yl)-5-ethyl-6-methylpyrimidin-4(3H)-one
CAS:Pureza:95.0%Peso molecular:259.312988281254-(5-(2,6-Dimethoxyphenyl)-3-(methoxycarbonyl)-1H-pyrazol-1-yl)-3-isopropylbenzoic acid
CAS:Pureza:95%Peso molecular:424.4530029296875cis-Hydroxy Praziquantel
CAS:<p>Applications The main cis-monohydroxylated metabolite of Praziquantel (P702095).<br>References Buehring, K., et al.: Eur. J. Drug Metab. Pharm., 3, 179 (1978), Moldeus, P., et al.: Methods Enzymol., 52, 60 (1978), Cioli, D., et al.: Pharmacol. Ther., 68, 35 (1995),<br></p>Fórmula:C19H24N2O3Cor e Forma:NeatPeso molecular:328.40Ethyl 2-(2-(2-fluorophenoxy)acetamido)-4-methyl-5-(phenylcarbamoyl)thiophene-3-carboxylate
CAS:Pureza:98%Peso molecular:456.4899902343752-Pyridin-4-yl-2,3-dihydro-1H-quinazolin-4-one
CAS:Cor e Forma:SolidPeso molecular:225.251007080078121-[2-(2,4-Difluorophenyl)-2,3-epoxypropyl]-1H-1,2,4-triazole
CAS:<p>Impurity Fluconazole EP Impurity G<br>Applications 1-[2-(2,4-Difluorophenyl)-2,3-epoxypropyl]-1H-1,2,4-triazole (Fluconazole EP Impurity G) is an epoxy impurity of the antifungal agent Fluconazole (F421000).<br>References Bourichi, H. et al.: STP Pharm. Prat., 18, 285 (2008); Dongre, V.G. et al.: J. Pharmac. Biomed. Anal., 42, 334 (2006):<br></p>Fórmula:C11H9F2N3OCor e Forma:NeatPeso molecular:237.21rac-Methyl Ephedrine-d3 Hydrochloride
CAS:Produto Controlado<p>Applications Labelled Ephedrine derivative for controlling respiratory tract goblet cell hyperplasia in respiratory diseases including infection and bronchitis.<br>References Tan, Z., et al.: J. Therm. Anal., 45, 59 (1995), van Berkel, G., et al.: Anal. Chem., 76, 479 (2004), Di, Y., et al.: Chin. Phy., 17, 3276 (2008),<br></p>Fórmula:C112H3H14NO·ClHCor e Forma:NeatPeso molecular:218.744,7-Bis(5-bromothiophen-2-yl)benzo[c][1,2,5]thiadiazole
CAS:Pureza:98%Cor e Forma:SolidPeso molecular:458.200012207031253-(4-methylphenyl)-1-phenyl-1H-pyrazole-4-carboxylic acid
CAS:Pureza:95.0%Cor e Forma:SolidPeso molecular:278.3110046386719(R)-6,7-Dimethoxy-2-methyl-N-(1-(4-(2-((methylamino)methyl)phenyl)thiophen-2-yl)ethyl)quinazolin-4-amine
CAS:Pureza:98.0%Cor e Forma:Liquid, No data available.Peso molecular:448.5899963378906Levetiracetam-d6
CAS:Produto Controlado<p>Applications Levetiracetam-d6 is a labelled (S)-enantiomer of the ethyl analog of Piracetam (P500800), an anticonvulsant.<br>References Gower, A.J., et al.: Eur. J. Pharmacol., 222, 193 (1992), Kasteleijn-Noist Trenite, D.G.A., et al.: Epilepsy Res., 25, 225 (1996), Patsalos, P.N., et al.: Pharmacol. Ther., 85, 77 (2000),<br></p>Fórmula:C8D6H8N2O2Cor e Forma:NeatPeso molecular:176.256-(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid
CAS:Pureza:95.0%Peso molecular:313.3609924316406Ref: 10-F469403
1gA consultar2gA consultar5gA consultar100mgA consultar250mgA consultar500mgA consultar2-(((3,5-Dimethylpyridin-2-yl)methyl)sulfinyl)-5-methoxy-1H-benzo[d]imidazole
CAS:Pureza:95.0%Peso molecular:315.3900146484375Ref: 10-F234475
1mgA consultar5mgA consultar10mgA consultar25mgA consultar50mgA consultar100mgA consultar250mgA consultar2-Methyl-4-(morpholin-4-yl)aniline
CAS:Fórmula:C11H16N2OPureza:97%Cor e Forma:SolidPeso molecular:192.262Benzydamine-d6 N-Oxide
CAS:Produto Controlado<p>Stability Hygroscopic<br>Applications A labelled metabolite of Benzydamine (B209950).<br>References Beaty, N., et al.: J. Biol. Chem., 255, 3817 (1980), Tugnait, M., et al.: Drug Metab. Dispos., 25, 524 (1997), Ubeaud, G., et al.: Eur. J. Pharm. Sci., 8, 255 (1999),<br></p>Fórmula:C19H17D6N3O2Cor e Forma:NeatPeso molecular:331.44(S)-Crizotinib
CAS:Produto Controlado<p>Applications (S)-Crizotinib is the S-isomer of Crizotinib (C785000) and a novel potent, selective, and cell permeable MTH1 inhibitor. (S)-Crizotinib can also serve as a promising anticancer agent.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Huber, K.V.M., et al.: Nature, 508, 222 (2014)<br></p>Fórmula:C21H22Cl2FN5OCor e Forma:Off-White To Light YellowPeso molecular:450.347-(4-Bromobutoxy)-3,4-dihydroquinolin-2-one
CAS:Produto Controlado<p>Impurity Aripiprazole Bromobutoxyquinoline Impurity<br>Stability Hygroscopic<br>Applications An impurity in the synthesis of Aripiprazole (A771000). A degradation product in Aripiprazole tablets. Aripiprazole Bromobutoxyquinoline Impurity<br>References Reddy, G.V.R., et al.: Eur. J. Chem., 1, 20 (2010),<br></p>Fórmula:C13H16BrNO2Cor e Forma:White To Off-WhitePeso molecular:298.18Linagliptin
CAS:<p>Applications Linagliptin is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.<br>References Prabavathy, N. et al.: Int. J. Pharm. Bio. Sci., 2, 438 (2011); Deacon, C.F.: Diab. Obes. Metab., 13, 7 (2011);<br></p>Fórmula:C25H28N8O2Cor e Forma:White To OrangePeso molecular:472.54α-Hydroxy Montelukast
CAS:Produto Controlado<p>Stability Hygroscopic<br>Applications A hydroxylated impurity of the selective leukotriene D4-receptor antagonist, Montelukast (M568000).<br></p>Fórmula:C35H36ClNO4SCor e Forma:NeatPeso molecular:602.184-bromo-2-(5-pyridin-3-yl-4,5-dihydro-1H-pyrazol-3-yl)phenol
CAS:Pureza:95.0%Peso molecular:318.174011230468754-(2-(Pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-ol
CAS:Pureza:95.0%Cor e Forma:SolidPeso molecular:328.3753-Vinylpyridine (>90%)
CAS:Produto ControladoFórmula:C7H7NPureza:>90%Cor e Forma:Light Yellow To Dark OrangePeso molecular:105.144-(4-ETHYNYLPHENYL)MORPHOLINE
CAS:Pureza:95.0%Cor e Forma:Liquid, No data available.Peso molecular:187.24200439453125Gabapentin Related Compound E
CAS:Produto Controlado<p>Impurity Gabapentin USP Related Compound E<br>Applications A Gabapentin (G117250) analogue. Gabapentin USP Related Compound E.<br>References Edafiogho, I., et al.: J. Med. Chem., 34, 387 (1991), Alexander, M., et al.: Eur. J. Med. Chem., 31, 787(1996), Obniska, J., et al.: Pharmacol. Rep., 57, 170 (2005)<br></p>Fórmula:C9H14O4Cor e Forma:NeatPeso molecular:186.21Methyl 2-(4-aminophenyl)quinoline-4-carboxylate
CAS:Pureza:95.0%Cor e Forma:SolidPeso molecular:278.3110046386719Pomalidomide
CAS:<p>Applications Pomalidomide is a thalidomide derivative, a potent inhibitor of TNF-α production. It is an antiinflammatory and antitumor agent used in the treatment of multiple myeloma.<br>References Ruchelman, A. et al.: Bioorg. Med. Chem. Lett., 23, 360 (2013); Latif, T. et al.: Exp. Hematol. Oncol., 1, 27 (2012); Man, H. et al.: Bioorg. Med. Chem. Lett., 13, 3415 (2003); Muller, G. et al.: Bioorg. Med. Chem. Lett., 9, 1625 (1999)<br></p>Fórmula:C13H11N3O4Cor e Forma:YellowPeso molecular:273.244-(thiophen-2-yl)-3H,4H,5H,6H,7H-imidazo[4,5-c]pyridine-6-carboxylic acid
CAS:Pureza:95.0%Peso molecular:249.2899932861328Furagin
CAS:Produto Controlado<p>Stability Hygroscopic<br>Applications Furagin (a nitrofurantoin analog) has the same efficacy in treating acute cystitis as Ciprofloxacin, however the duration of therapy is longer. Antibacterial.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Agace, W., et al.: J. Clin. Invest., 92, 780 (1993); Lawrenson, R., et al.: J. Antimicrob. Chemother., 48, 895 (2001); Dalhoff, A., et al.: Lancet Infect. Dis., 3, 359 (2003); Thumbikat, P., et al.: J. Immunol., 176, 3080 (2006);<br></p>Fórmula:C10H8N4O5Cor e Forma:NeatPeso molecular:264.19(S)-Mephenytoin
CAS:<p>Applications An anticonvulsant agent.<br>References Shimada, et al.: Anal. Biochem., 147, 174 (1975), Dzhagatspanyan. IA., et al.: Pharm. Chem. J., 25, 181 (1991),<br></p>Fórmula:C12H14N2O2Cor e Forma:Off-WhitePeso molecular:218.25Rivastigmine Tartrate Salt
CAS:Produto ControladoFórmula:C14H22N2O2·C4H6O6Cor e Forma:White To Off-WhitePeso molecular:400.42Ref: 10-F614479
1gA consultar2gA consultar5gA consultar100mgA consultar250mgA consultar500mgA consultarMDV 3100-d3
CAS:Produto Controlado<p>Applications Labelled MDV 3100. MDV 3100 is an androgen-receptor antagonist that blocks androgens from binding to the androgen receptor and prevents nuclear translocation and co-activator recruitment of the ligand-receptor complex. MDV 3100 has also been shown to induce tumor cell apoptosis, and has no agonist activity. MDV 3100 is a candidate for the treatment of castration-resistant prostate cancer.<br>References Scher, H.I. et al.: Lancet, 375, 1437 (2010); Bellmunt, J. et al.: Ther. Adv. Med. Oncol., 2, 189 (2010); Ryan, C.J. et al.: J. Clin. Oncol., 29, 3651 (2011);<br></p>Fórmula:C21H13D3F4N4O2SCor e Forma:NeatPeso molecular:467.457-chloro-8-methyl-2-pyridin-2-ylquinoline-4-carboxylic acid
CAS:Pureza:95.0%Peso molecular:298.7300109863281Ticagrelor Amine Derivative
CAS:Produto Controlado<p>Stability Hygroscopic<br>Applications Ticagrelor Amine Derivative is a metabolite of Ticagrelor (T437700). Ticagrelor is a reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS).<br>References Matetzky, S., et al.: Circulation, 109, 3171 (2004), Bassand, J., et al.: Eur. Heart J., 28, 1598 (2007), Jakubowski, J., et al.: Cardiovasc. Drug Rev., 25, 357 (2007),<br></p>Fórmula:C23H29F2N7O3SCor e Forma:White To Off-WhitePeso molecular:521.584-Phenyl-2-(pyridin-3-yl)thiazole
CAS:Pureza:95.0%Cor e Forma:Liquid, No data available.Peso molecular:238.309997558593754-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide
CAS:Pureza:99.0%Cor e Forma:SolidPeso molecular:482.82000732421875Ref: 10-F361865
1gA consultar5gA consultar10gA consultar25gA consultar10mgA consultar50mgA consultar100mgA consultar250mgA consultar500mgA consultar5-(PYRIDIN-4-YL)-2,3-DIAZABICYCLO[4.2.0]OCTA-1,5-DIEN-4-ONE
CAS:Pureza:95.0%Peso molecular:199.21299743652344NN'-Bis(2-hydroxyethyl)urea
CAS:<p>Applications NN'-Bis(2-hydroxyethyl)urea (cas# 15438-70-7) is a useful research chemical.<br></p>Fórmula:C5H12N2O3Cor e Forma:NeatPeso molecular:148.16N-Methylnitroacetamide
CAS:Produto Controlado<p>Impurity Ranitidine EP Impurity H<br>Applications N-Methylnitroacetamide (Ranitidine EP Impurity H) is a degradation product of Ranitidine (R120000).<br>References Sharma, N. et al.: Sci. Pharmac., 79, 309 (2011); Haywood, P.A. et al.: J. Chem. Soc., 5, 951 (1987);<br></p>Fórmula:C3H6N2O3Cor e Forma:NeatPeso molecular:118.09Furazolidone
CAS:<p>Applications Antimicrobial.Environmental contaminants; Food contaminants; Heat processing contaminants<br>References Yurchenco, J.A., et al.: Antimicrob. Chemother., 3, 1035 (1953), Sharma, C., et al.: J. Clin. Microbiol., 36, 756 (1998),<br></p>Fórmula:C8H7N3O5Cor e Forma:YellowPeso molecular:225.16
![2-[(4-METHYL-1-PIPERAZINYL)METHYL]-6-QUINOLINAMINE](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF468212.webp&w=3840&q=75)
![N-methyl-N-[(5-methyl-1-phenyl-1H-pyrazol-4-yl)methyl]amine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF518928.webp&w=3840&q=75)
![10,11-Dihydro-11-[4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]dibenzo[b,f][1,4]thiazepin-11-ol](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FQ510033.webp&w=3840&q=75)
![[4-(5-pyridin-3-yl-1H-1,2,4-triazol-3-yl)phenyl]amine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF496128.webp&w=3840&q=75)
![5-Benzo[1,3]dioxol-5-yl-1 H -pyrazole-3-carboxylic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF027887.webp&w=3840&q=75)
![4-Phenyl-5-pyridin-4-yl-4H-[1,2,4]triazole-3-thiol](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF039130.webp&w=3840&q=75)
![1-[2-(2,4-Difluorophenyl)-2,3-epoxypropyl]-1H-1,2,4-triazole](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD446045.webp&w=3840&q=75)
![4,7-Bis(5-bromothiophen-2-yl)benzo[c][1,2,5]thiadiazole](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF791133.webp&w=3840&q=75)
![[1,1'-biphenyl]-4-yl(2-chloropyridin-4-yl)methanone](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF614704.webp&w=3840&q=75)
![6-(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF426603.webp&w=3840&q=75)
![2-(((3,5-Dimethylpyridin-2-yl)methyl)sulfinyl)-5-methoxy-1H-benzo[d]imidazole](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF234475.webp&w=3840&q=75)
![4-(2-(Pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-ol](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF321517.webp&w=3840&q=75)
![4-(thiophen-2-yl)-3H,4H,5H,6H,7H-imidazo[4,5-c]pyridine-6-carboxylic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF522494.webp&w=3840&q=75)
![5-(PYRIDIN-4-YL)-2,3-DIAZABICYCLO[4.2.0]OCTA-1,5-DIEN-4-ONE](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF332614.webp&w=3840&q=75)
